M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 14.77 USD -1.73% Market Closed
Market Cap: $1.1B

Wall Street
Price Targets

MLTX Price Targets Summary
MoonLake Immunotherapeutics

Wall Street analysts forecast MLTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLTX is 20.05 USD with a low forecast of 2.02 USD and a high forecast of 47.25 USD.

Lowest
Price Target
2.02 USD
86% Downside
Average
Price Target
20.05 USD
36% Upside
Highest
Price Target
47.25 USD
220% Upside
MoonLake Immunotherapeutics Competitors:
Price Targets
PWP
Perella Weinberg Partners
6% Upside
AKTIA
Aktia Bank Abp
4% Upside
IDXX
IDEXX Laboratories Inc
21% Upside
LGI
Lgi Ltd
33% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MLTX's stock price target?
Price Target
20.05 USD

According to Wall Street analysts, the average 1-year price target for MLTX is 20.05 USD with a low forecast of 2.02 USD and a high forecast of 47.25 USD.

Back to Top